Repligen | RGEN - EPS Earnings Per Share


Repligen reported $0.48 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.47 0.46 Nov/03
FY2026Q2 Jun/2026 0.45 0.37 Aug/04
FY2026Q1 Mar/2026 0.48 0.39 0.39 May/05
FY2025Q4 Dec/2025 0.49 0.44 0.44 Feb/24
FY2025Q3 Sep/2025 0.46 0.42 0.43 Oct/28




Eps Change Date
Agilent USD 1.43 0.11 Mar/2026
Align Technology USD 2.58 0.71 Mar/2026
Bio Techne USD 0.53 0.07 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Bruker USD 0.31 0.28 Mar/2026
Charles River Laboratories USD 2.06 0.33 Mar/2026
Danaher USD 2.06 0.17 Mar/2026
Dentsply International USD 0.27 0.2 Mar/2026
General Electric Aerospace USD 2.02 0.16 Jun/2026
Henry Schein USD 1.32 0.02 Mar/2026
Illumina USD 1.15 0.2 Mar/2026
IQVIA Holdings USD 2.9 0.52 Mar/2026
Mettler Toledo International USD 8.91 4.45 Mar/2026
Myriad Genetics USD -0.09 0.13 Mar/2026
OraSure Technologies USD -0.18 0 Dec/2025
Pacific Biosciences Of California USD -0.17 0.12 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Repligen USD 0.48 0.01 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Standard Biotools USD 0.33 0.29 Mar/2026
Thermo Fisher Scientific USD 5.44 1.13 Mar/2026
Waters USD 2.7 1.83 Mar/2026
West Pharmaceutical Services USD 2.13 0.09 Mar/2026